The histologic characteristics of atopic dermatitis (AD) include perivascular edema and dilated tortuous vessels in the papillary dermis. A single nucleotide polymorphism (SNP) of the fms-related tyrosine kinase 4 (FLT4) gene is associated with AD. Objective: To investigate the associations between podoplanin (PDPN) gene SNPs and AD. Methods: We genotyped 9 SNPs from 5 genes of 1,119 subjects (646 AD patients and 473 controls). We determined the promoter activity of 1 SNP (rs355022) by luciferase assay; this SNP was further investigated using 1,133 independent samples (441 AD patients and 692 controls). Results: The rs355022 and rs425187 SNPs and the C-A haplotype in the PDPN gene were significantly associated with intrinsic AD in the initial experiment. The rs355022 SNP significantly affected promoter activity in the luciferase assay. However, these results were not replicated in the replication study. Conclusion: Two SNPs and the C-A haplotype in the PDPN gene are significantly associated with intrinsic AD; although, the results were confirmed by luciferase assay, they could not be replicated with independent samples. Nevertheless, further replication experiments should be performed in future studies. (Ann Dermatol 27(3) 275∼282, 2015) 
INTRODUCTION
Atopic dermatitis (AD) is a genetically complex disease involving gene-gene and gene-environment interactions 1 .
Genetic linkage analysis and association studies have identified several candidate genes associated with either epidermal barrier function or the immune system. Stress, bacterial, or viral infections, exposure to airborne or food allergens, and hygienic factors are thought to aggravate AD symptoms 1 .
The K14-IL-4 transgenic mouse model of AD demonstrates that progressive dermal lymphatic growth is a prominent feature of AD; this is characterized by increased vessel number, vessel diameter, and the percent vascularized area 2 . This transgenic mouse model exhibits significantly increased dermal expression of podoplanin (PDPN), lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), and fms-related tyrosine kinase 4 (FLT4, vascular endothelial growth factor receptor 3 [VEGFR 3]). The histological findings of human AD include dilated tortuous vessels within the papillary dermis, perivascular edema, mononuclear cell accumulation, and rare neutrophils and eosinophils 3 . However, the role of the dermal vasculature in AD pathogenesis remains poorly understood. PDPN/T1a/aggrus/PA2.26 antigen, a transmembrane glycoprotein, is a well-known lymphatic endothelial marker. PDPN expression surrounding malignant tumors is a prognostic factor associated with lymphangiogenesis and distant metastasis 4 . Immunostaining with D2-40 mouse monoclonal antibody shows that PDPN is highly expressed in lymphatic endothelial cells and the basal cell layer of sebaceous glands but not in normal human interfollicular epidermis 5 . Marked PDPN expression is detected in the outer root sheath of hair follicles from the mid portion to the hair bulb excluding the bulge area 5 . Gröger et al. 6 report that PDPN and LYVE-1 are not only lineage markers for lymphatic endothelial cells, but also activation markers of blood endothelial cells. In normal skin, they found 2 types of vessels: vessels expressing high levels of PDPN (i.e., lymphatic vessels), and vessels negative for PDPN (i.e., blood vessels). However, within the papillary dermis in cases of eczema and psoriasis, they found a third type of vessel expressing low amounts of PDPN. Henno et al. 7 report that lymphatic vessels are expressed after blood vascular development in psoriasis.
We previously reported that single nucleotide polymorphisms (SNPs) and haplotypes of the FLT4 and VEGFA genes are associated with psoriasis 8 and that the rs10085109 SNP in the FLT4 gene is associated with AD susceptibility 9 . These results suggest FLT4 may increase dermal vasculature in Korean patients with AD and psoriasis. Therefore, in the current study, we performed a similar experiment comparing patients with AD with normal controls to determine the association between PDPN SNPs and AD in Korean. defines bins of SNPs that are in very strong linkage disequilibrium with a specified r 2 threshold; one SNP is then selected to represent the remaining SNPs in a bin 13 . We used an r 2 threshold of 0.8 and a minimum allele frequency of 0.1. Thus, a total of 9 SNPs from PDPN were selected as markers for the association study ( Fig. 1 ).
MATERIALS AND METHODS

Subjects
Genotyping with fluorescence polarization detection
We extracted genomic DNA from 5-ml whole blood samples by using a commercially available DNA isolation kit (Gentra Genomic DNA Purification Kit; Qiagen, Minneapolis, MIN, USA) in accordance with the manufacturer's protocol. Genotypes were identified with the ultra-high throughput GenomeLab SNPstream system 14 , which uses multiplex polymerase chain reaction (PCR) in conjunction with tag array single-base extension genotyping technology (Beckman Coulter, Fullerton, CA, USA) and the SNPstream software suite 15 . PCR amplifications were performed in a PTC-225 Peltier Thermal Cycler (MJ Research, Waltham, MA, USA) with Taq Gold DNA polymerase (Applied Biosystems, Foster City, CA, USA). The sequences of the PCR primers and extension primers are available upon request. Multiplex PCR and genotyping were performed in homogeneous reactions, and the assay results were read by direct two-color fluorescence on the SNPstream Ultra-High Throughput Array Imager. Individual genotypes were generated on the basis of the relative fluorescent intensities for each SNP and processed for graphical review. All genotyping results were reviewed and confirmed manually by experienced researchers.
Luciferase assay
Double-stranded oligonucleotides were synthesized with three concatenated copies of the T or C allele for a 21-bp region centered on the polymorphism with KpnI and BglII at the 5′ and 3′ ends, respectively. The oligonucleotides were subsequently cloned into the pGL3-promoter vector (Promega, Madison, WI, USA), which has a simian virus 40 (SV40) promoter. HEK293 cells were transfected with 1 μg reporter constructs and 0.1 μg pRL-TK Renilla luciferase vector (Promega) with Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer's protocol. The transfection efficiency was normalized to that of Renilla luciferase activity. The medium was changed to growth medium 18 hours after transfection. Cells were harvested 24 hours after the medium was changed, and the luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega).
Statistical analysis
The χ 2 test was used to determine if individual variants were in Hardy-Weinberg equilibrium at each locus for normal samples. The allelic (i.e., additive) and genotypic effects of individual SNPs were tested using a logistic regression model adjusted for sex and age. The level of significance was set at p＜0.05. Odds ratios (ORs) and 95% confidence intervals (CIs) were also estimated from the logistic regression model. To detect the most significantly associated haplotype, the significance of overall haplotype effects was scanned for haplotypes of 2 to 4 SNPs by using a sliding-window approach. For the haplotype scan, the haplo.score function in the R package (http://www.r-project.org) was used; this function is a haplotype association test method that enables the simultaneous modeling of haplotype effects including various controlling covariates, and statistical significance is determined according to score test statistics 16 .
Haplo.score provides global test statistics for a given haplotype locus in addition to results for individual haplotypes. For loci that had a significant effect in individual SNP tests, we obtained the combined effect by using the hap- 
RESULTS
Nine SNPs of the PDPN gene were genotyped in the 1,119 subjects at the initial stage. Information on the SNPs, including genomic function, chromosomal position, dbSNP ID, and minor allele frequency, is shown in Table 2 . All SNPs were in Hardy-Weinberg equilibrium at a significance level of 0.01. The average genotyping success rate was 99.3%. We compared the distributions of the allelic and genotypic frequencies for the 9 SNPs between the AD and NR groups. Statistical significance was obtained in logistic regression analysis adjusted for age and sex. For further analysis, haplotype association tests were conducted using a sliding window approach.
Associations of polymorphism gene single nucleotide polymorphisms with atopic dermatitis
Regarding the associations of the SNPs with AD, two SNPs (rs355022 and rs425187) had significantly different allelic or genotypic distributions between the ADi and NR groups (Table 3) ; rs355022 exhibited a greater difference between groups (p=0.016, OR=0.587, 95% CI: 0.38∼ 0.907). The genotypic effect test showed a significant difference in the rs425187 SNP (p=0.043) with ORs of 0.616 (95% CI: 0.316∼1.204) for A-A vs. A-G and 6.444 (95% CI: 1.021∼40.678) for A-A vs. G-G (Table 3) . To calculate the combined effect size of the two loci, we used the haplo.glm function to estimate haplotypes simultaneously in a generalized linear model. The haplotype C-A of the two loci was significantly associated with ADi (p=0.03), and the OR vs. T-A was 0.603 (95% CI: 0.382∼ 0.952). Although no other haplotypes showed significant associations, the C-G group, which has two risk alleles, tended to have an increased effect for ADi compared to individual SNPs (Table 4 ).
rs355022 single nucleotide polymorphism luciferase assay
Because rs355022 is located in the promoter (−1611 C/T) region of the PDPN gene, its effect rs355022 on transcriptional activity was examined by luciferase reporter assay (Fig. 2) . Luciferase gene constructs containing three concatenated copies of a 21-bp region of either the T or C allele centered on the SNP (i.e., p3X1562T and p3X1562C) were prepared. Transfecting p3X1562C into HEK293 cells decreased luciferase activity to a greater extent than p3X1562T (0.44±0.25 fold induction) (Fig. 2) . This result suggests rs355022 affects the transcriptional activity of the PDPN gene.
Replication of the single nucleotide polymorphism experiments
To confirm the effects of rs355022 and rs425187, we genotyped 1,133 independent samples from 441 patients with AD and 692 controls (Table 1) . However, rs425187 did not exhibit any association, while rs355022 exhibited a significant association in the replicate samples (data not shown). Thus, the direction of the effect was opposite to that of the initial study. Therefore, the association became non-significant for the merged dataset (Table 5) .
DISCUSSION
PDPN is a sensitive marker for identifying lymphatic vessels. Transgenic mice exhibit significantly elevated dermal expression of PDPN, LYVE-1, and VEGFR-3 (FLT4) 5 , suggesting lymphatic vessels may be involved in AD pathogenesis in the animal model. VEGF and effector cells of skin inflammation (i.e., mast cells, basophils, eosinophils, macrophages lymphocytes, etc.) are major sources of the vast array of angiogenesis and lymphangiogenesis in AD. However, the role of lymphangiogenesis in AD is largely unknown 3 .
We previously reported that a SNP in the FLT4 gene is associated with AD susceptibility in Koreans 9 . On the basis of these reports, we hypothesized PDPN is associated with AD and therefore evaluated the association between the SNPs of PDPN and AD susceptibility. We initially identified two SNPs, rs355022 and rs425187, in the PDPN gene that were significantly associated with intrinsic AD in Koreans. As the rs355022 SNP is located in the promoter region of PDPN (−1611 C/T), we performed a luciferase assay; the results show that rs355022 can affect PDPN transcription, which indicates PDPN SNP T→C is associated with lower transcriptional activity of PDPN.
To confirm these findings, we replicated the experiment with a different set of patients and controls. However, the replication study did not confirm the results of the initial experiment. The reason for the contrasting results of our two experiments is unknown. It is possible that the SNPs in PDPN gene weakly influence the whole-protein effect of this gene in vivo. This discrepancy highlights the importance of replication studies for SNPs. The role of dermal vasculature in AD pathogenesis is controversial 3 . Our previous results suggest there might be differences between the K14-IL-4 transgenic mouse model and humans 5 . In the K14-IL-4 transgenic mouse model, interleukin (IL)-4-triggering macrophage recruitment has been suggested to be closely associated with lymphangiogenesis in AD. However, in comparison to K14-IL-4 transgenic mice, the active action time of IL-4 is not long enough in humans to sustain macrophage recruitment.
